Views: 0 Author: Site Editor Publish Time: 2026-02-02 Origin: Site
PVC/PE/PVDC pharmaceutical blister film is a multilayer thermoformable packaging structure designed for pharmaceutical products that require a stronger moisture and oxygen barrier than conventional rigid PVC while also benefiting from improved forming flexibility.
Often described as a triplex blister film, the structure combines rigid PVC for thermoforming support, a PE functional layer for flexibility and processing performance, and PVDC for moisture, oxygen and gas barrier protection.
For pharmaceutical manufacturers and blister converters, however, simply specifying “PVC/PE/PVDC” is not enough. The final structure should be selected according to drug stability, target WVTR, target OTR, PVDC coating weight, cavity depth, forming conditions, lidding foil, sealing window, blister machine and destination-market requirements.
Wallis supplies high-barrier PVC/PE/PVDC pharmaceutical blister film with customized thickness, PVDC coating weight, width, color and roll configuration for B2B pharmaceutical packaging projects.
PVC/PE/PVDC is a three-component pharmaceutical packaging structure in which each material contributes a different function. This allows the complete film to balance rigidity, forming behavior, flexibility and barrier performance more effectively than relying on a single polymer.
The rigid PVC layer provides the main dimensional stability and thermoforming support. During blister production, the web is heated and formed into cavities that hold tablets, capsules or other suitable pharmaceutical products.
PVC also helps provide the stiffness required for winding, machine transport, forming and downstream blister handling.
PE is more flexible than rigid PVC. In a PVC/PE/PVDC triplex structure, the PE layer can improve toughness and help the multilayer web tolerate greater deformation during thermoforming.
This is one reason triplex films are frequently evaluated for deeper or wider blister cavities. The exact forming benefit depends on PE thickness, total laminate thickness, cavity geometry, heating profile and tooling.
PVDC provides the primary high-barrier function by reducing the transmission of water vapor, oxygen and other gases through the packaging structure.
PVDC coating weight is an important specification, but it is not the only factor determining final barrier performance. PVDC formulation, coating uniformity, substrate structure, thermoforming conditions and finished cavity geometry can all influence measured performance.
The major difference between conventional PVC/PVDC duplex film and PVC/PE/PVDC triplex film is the additional PE layer. This layer changes the mechanical and processing behavior of the forming web.
PE introduces a more flexible intermediate layer between the rigid PVC structure and the PVDC barrier layer. This can improve overall toughness and help reduce stress during selected forming operations.
Triplex film is commonly considered when a blister requires greater material deformation, such as larger tablets, capsules, soft gels or other products requiring deeper cavity geometry.
PE can contribute to sealing functionality in appropriately designed multilayer structures, but buyers should not assume that every PVC/PE/PVDC film automatically seals directly to every aluminum foil.
Final sealing performance depends on the exposed sealing surface, lidding-foil heat-seal lacquer, temperature, pressure, dwell time and machine configuration. The forming web and lidding material should be qualified together.
The following values summarize the current Wallis product range. Final layer ratios, dimensional tolerances, coating weight and barrier values should be confirmed for the exact pharmaceutical project.
| Product | High-Barrier PVC/PE/PVDC Pharmaceutical Blister Film |
| Material Structure | PVC / PE / PVDC multilayer composite |
| Total Thickness | Approximately 50–400 μm; customized according to project requirements |
| PVDC Coating Weight | Approximately 60–120 g/m²; final selection according to required barrier performance |
| Typical Width | Approximately 250–350 mm; customized widths subject to production confirmation |
| Supply Form | Roll |
| Color | Transparent, tinted and customized colors |
| Thermoforming | Suitable structures can be evaluated for standard, deep and wide blister cavities |
| Barrier | High moisture and oxygen barrier; specify target WVTR and OTR with test conditions |
| Typical Applications | Tablets, capsules, soft gels, nutraceuticals and selected high-barrier pharmaceutical blister packs |
| Customization | Layer ratio, thickness, coating weight, width, color and roll configuration |
PVDC coating weight is one of the most important variables in high-barrier blister-film design. In general, increasing an appropriately formulated PVDC coating can reduce moisture and oxygen transmission through the film.
However, coating weight should not be treated as a substitute for measurable barrier data.
A lower coating-weight specification within the Wallis range can be evaluated when the pharmaceutical product needs a meaningful improvement over plain PVC but does not require the highest barrier level available from the triplex family.
Intermediate PVDC coating weights may be evaluated when stronger moisture and oxygen protection is required while maintaining transparent thermoformed blister packaging.
Higher coating weights within the current Wallis range can provide stronger barrier performance. Extremely moisture-sensitive formulations may still require comparison with super-high-barrier PVDC, PCTFE-based film or cold-form aluminum.
Two films with the same nominal PVDC coating weight can have different WVTR and OTR values because coating chemistry, uniformity, PE layer, PVC substrate and processing conditions may differ.
Pharmaceutical buyers should therefore define barrier targets using measurable transmission values together with the applicable test conditions.
Water Vapor Transmission Rate (WVTR) indicates the amount of water vapor that passes through a packaging material under defined test conditions. Lower WVTR generally indicates stronger moisture-barrier performance.
WVTR is particularly important for hygroscopic tablets, capsules and formulations whose chemical or physical stability is affected by moisture.
Oxygen Transmission Rate (OTR) indicates the amount of oxygen passing through the packaging material under specified conditions. Lower OTR is desirable when oxidation is an important stability risk.
Barrier figures should be compared only when temperature, relative humidity, thickness and test method are equivalent. A WVTR or OTR number without its test conditions is not a complete pharmaceutical packaging specification.
PVDC can substantially reduce moisture transmission compared with conventional mono PVC, allowing triplex film to be evaluated for pharmaceutical products affected by humidity exposure.
PVDC also contributes oxygen and gas barrier performance, making PVC/PE/PVDC relevant when oxidation or gas exposure is part of the drug-stability profile.
The more flexible PE layer can make selected triplex structures useful for deeper or wider blister cavities compared with more rigid structures. Production trials should still be performed on the intended blister machine and tooling.
Transparent triplex structures can maintain product visibility while providing a stronger barrier than standard clear PVC. This can be useful when visual inspection and transparent blister presentation are required.
Total thickness, PE layer, PVDC coating weight, color, width and roll configuration can be discussed according to the drug's stability target and the packaging line.

A pharmaceutical blister film is stretched during thermoforming. As the material is drawn into a cavity, individual layers can become thinner at the sidewalls, corners and deepest sections.
This means the barrier performance of a flat roll sample is not necessarily identical to the barrier performance of the finished blister cavity.
Deeper cavities and aggressive draw ratios can create greater material thinning. Tablet dimensions, capsule dimensions, cavity depth, corner radius and web thickness should therefore be evaluated together.
Heating temperature, heating time, tooling and forming pressure or vacuum can affect material distribution across the cavity.
Critical pharmaceutical projects should validate the formed and sealed blister under the intended production and stability conditions rather than relying only on a flat-film TDS.
| Structure | Primary Strength | Typical Selection Logic |
|---|---|---|
| Plain PVC | Economical thermoforming and clarity | Products where standard PVC barrier is sufficient |
| PVC/PVDC | Higher moisture and oxygen barrier | Conventional high-barrier transparent blister packs |
| PVC/PE/PVDC | Barrier plus improved multilayer forming flexibility | Projects balancing high barrier with deeper or wider cavities |
| Super-High-Barrier PVDC | Higher barrier within transparent PVDC systems | When standard PVDC coating levels do not meet the target WVTR or OTR |
| PCTFE-Based Film | Very high moisture barrier | Highly hygroscopic drugs requiring stronger moisture protection |
| Cold-Form Aluminum | Very high moisture, oxygen and light protection | Maximum barrier where transparent product visibility is unnecessary |
The highest-barrier structure is not automatically the best option. Packaging engineers should select the material that meets the drug-stability requirement while also maintaining acceptable forming performance, package size, machine efficiency and total packaging cost.
PVC/PE/PVDC can be evaluated for tablets requiring stronger moisture and oxygen protection than conventional PVC while retaining transparent thermoformed packaging.
Capsules and soft gels can require larger or deeper cavities. Triplex structures can be evaluated where improved formability and high barrier are both important.
PVDC-based structures can help reduce humidity exposure for moisture-sensitive pharmaceuticals. The required coating weight should be determined by the formulation's stability data rather than selected from a generic “high-barrier” label.
Vitamins, probiotics and other oxygen- or moisture-sensitive nutraceutical products can also be evaluated with PVC/PE/PVDC when the measured barrier performance meets their shelf-life requirements.
Products distributed into hot or humid regions may need higher moisture-barrier performance than products stored under less demanding environmental conditions. Packaging selection should be aligned with the intended stability-storage and distribution environment.
A blister pack is a complete packaging system. The forming web cannot be qualified independently from the lidding material and sealing process.
Buyers should specify the intended aluminum foil or polymer lidding film, including the heat-seal lacquer where relevant.
Seal initiation and optimum sealing temperatures depend on both sides of the packaging system. Excessive temperature can also influence film deformation and line performance.
Seal pressure and dwell time should be optimized together with temperature to establish a reliable sealing window at the intended machine speed.
Finished blister packs should be evaluated for seal quality and package integrity using appropriate validated methods for the intended product and market.
Suitable PVC/PE/PVDC structures can be evaluated on commercial pharmaceutical blister lines, including rotary and flat-bed forming systems.
Machine compatibility depends on the exact blister machine, forming temperature, heating-zone design, cavity geometry, roll width, web tension, sealing window and line speed.
Buyers changing from PVC/PVDC to PVC/PE/PVDC should therefore run a production trial rather than assuming that the existing processing settings can remain unchanged.
A statement such as “pharmaceutical grade” or “complies with pharmaceutical standards” should not be treated as universal approval for every medicinal product or destination market.
Packaging suitability depends on the complete container-closure system and should be evaluated for protection, compatibility, safety and performance in relation to the intended pharmaceutical product.
Buyers should request documentation applicable to the exact grade, structure and destination market and complete their own pharmaceutical packaging qualification and stability program.
High-barrier pharmaceutical film requires control of both dimensional properties and multilayer performance.
Total thickness: confirm nominal gauge and tolerance.
PVDC coating weight: verify against the approved barrier specification.
Coating uniformity: inconsistent coating can influence barrier and forming performance.
Interlayer bond strength: inspect for delamination during winding, heating and thermoforming.
WVTR and OTR: test according to agreed environmental conditions and methods.
Optical quality: inspect transparency, haze, contamination and visible defects where applicable.
Roll width and winding: confirm suitability for the intended blister line.
Thermoforming trial: evaluate cavity definition, thinning, cracking and web stability.
Seal trial: qualify the actual forming web together with the selected lidding material.
Determine whether moisture, oxygen, light or another environmental factor is the main degradation risk.
Replace vague terms such as “very high barrier” with measurable target values whenever possible.
Provide tablet or capsule size, cavity depth, corner radius and blister drawing so the required forming behavior can be evaluated.
Machine model, forming method, line speed, roll width, heating system and tooling information can reduce qualification risk.
The bottom forming web and lidding foil should be selected and tested as a complete sealing system.
Use coating weight as one design variable, but approve the final structure based on measured barrier and stability requirements.
Test the material on the intended production equipment and inspect formed-cavity quality, delamination, seal integrity and machine stability.
Final shelf-life suitability should be supported by the pharmaceutical manufacturer's validated stability program using the actual packaging system.
Application: tablet, capsule, soft gel, nutraceutical or other pharmaceutical blister.
Current structure: existing PVC/PE/PVDC specification or supplier TDS if available.
Total thickness: required nominal thickness and tolerance.
PE layer: required thickness or existing structure if already defined.
PVDC coating weight: 60, 90, 120 g/m² or other validated requirement.
Target WVTR: include temperature, relative humidity and test method.
Target OTR: include temperature, relative humidity and test method.
Roll width: required slit width.
Roll specification: core diameter, maximum OD, winding direction and roll weight where required.
Color: transparent, tinted or customized.
Blister machine: manufacturer, model, rotary or flat-bed forming and expected line speed.
Cavity drawing: product dimensions, cavity depth and forming geometry.
Lidding foil: foil structure and heat-seal lacquer specification.
Destination climate: expected storage and distribution environment.
Destination market: required pharmaceutical documentation or regulatory references.
Quantity: trial quantity, validation requirement and expected commercial demand.
Barrier structures can be discussed according to target moisture and oxygen transmission rather than using one universal coating configuration for every pharmaceutical application.
Total thickness, width and roll configuration can be matched to customer blister equipment and approved packaging drawings subject to production confirmation.
Trial material can be evaluated for thermoforming behavior, cavity geometry and sealing compatibility before commercial qualification.
Wallis supports pharmaceutical packaging converters, medicine manufacturers, distributors and healthcare packaging buyers requiring customized high-barrier roll materials.

PVC/PE/PVDC is a multilayer blister film combining rigid PVC thermoforming support, a flexible PE functional layer and a PVDC coating that provides moisture and oxygen barrier performance.
Triplex generally refers to a three-component pharmaceutical forming structure such as PVC/PE/PVDC. It is commonly selected when both high barrier and improved forming behavior are required.
PVC/PVDC combines a rigid PVC base with PVDC barrier coating. PVC/PE/PVDC adds a PE layer that can improve flexibility and processing performance, making the structure useful to evaluate for deeper or wider cavities.
PE provides additional flexibility and can improve multilayer processing and forming behavior. Depending on the exact structure, it may also contribute to sealing functionality.
PVDC reduces water-vapor, oxygen and gas transmission, providing the principal high-barrier function in the triplex structure.
The current Wallis product range lists approximately 60–120 g/m². Final coating weight should be selected according to the required WVTR, OTR and packaging qualification.
A higher coating weight can provide stronger barrier performance within an appropriately designed system, but the best specification is the one that meets the drug's stability requirement while maintaining suitable forming, cost and machine performance.
Yes, suitable triplex structures can be evaluated for deep or large cavities. Actual capability depends on total thickness, PE layer, cavity geometry, forming temperature and tooling.
It can be used with compatible pharmaceutical lidding systems, but seal performance depends on the exposed forming-web surface, aluminum-foil heat-seal lacquer and the sealing temperature, pressure and dwell time. The actual materials should be tested together.
Yes, it can be evaluated for tablet and capsule blister packaging when the selected structure satisfies the drug's moisture, oxygen, forming, compatibility and stability requirements.
It can be evaluated for selected soft-gel packages where larger cavities require both barrier and forming performance. Product compatibility and stability should be confirmed before commercial use.
It can provide high moisture and oxygen barrier, but “ultra-high barrier” should be defined using measurable WVTR and OTR values. Extremely sensitive products may require comparison with super-high-barrier PVDC, PCTFE or cold-form aluminum.
Yes. Thermoforming stretches the material and can reduce layer thickness at cavity walls and corners. Critical projects should evaluate the actual formed blister rather than only the flat-film specification.
Suitable structures can be evaluated on both systems, but forming conditions differ. Buyers should provide the exact blister-machine model and run production trials before commercial qualification.
No packaging material independently guarantees a specific shelf life. PVC/PE/PVDC can reduce moisture and oxygen exposure, but expiry dating must be established through the pharmaceutical manufacturer's validated stability program using the complete packaging system.
Yes. Buyers should test thermoforming, cavity quality, sealing, roll performance, interlayer adhesion and relevant barrier requirements on the intended packaging line before approving bulk production.
PVC/PE/PVDC triplex film is valuable because it combines three different functions: PVC provides thermoforming support, PE contributes flexibility and processing performance, and PVDC provides the primary moisture and oxygen barrier.
The correct pharmaceutical packaging structure should therefore be chosen from measurable requirements rather than terms such as “TOP-grade” or “maximum barrier.”
Provide Wallis with your target WVTR and OTR, total thickness, PVDC coating weight, cavity drawing, blister-machine model, lidding foil, roll width, destination market and expected quantity to discuss suitable samples and customized production.
Colored Magnetic Stripe Film Guide for Plastic Card Manufacturing
PVC vs PETG Edge Banding Guide: Materials, Finishes & Selection
RFID & NFC Inlay Guide 2026: Smart Card Types, Selection & Quality Control
High Transparency Anti-Blue Light PET TV Baffle: Custom Screen Protector Guide
Custom Blister Packaging with PVC Rigid Film: Design, Performance & Applications
Top 15 Durable Transparent Poker Playing Cards Manufacturers in Brazil 2026
Inkjet Printable PVC, PETG and Polycarbonate Sheets for Card Making
The Manufacturing Process of Inlay: From RFID Chip Assembly to Quality Control
PVC, PC & PET Magnetic Stripe Films: Smart Card Buying Guide
Start Your Project with Us